| MR编号 | UK/H/5613/001 | ||||||
|---|---|---|---|---|---|---|---|
| 药品名称 | Lansoprazole 15mg orodispersible tablets | ||||||
| 活性成分 |
| ||||||
| 剂型 | Orodispersible tablet | ||||||
| 上市许可持有人 | STADA Arzneimittel AG, StadastraBe 2-18, 61118 Bad Vilbel, Germany | ||||||
| 参考成员国 - 产品名称 | United Kingdom (UK) Lansoprazole 15mg orodispersible tablets | ||||||
| 互认成员国 - 产品名称 |
| ||||||
| 许可日期 | 2015/12/15 | ||||||
| 最近更新日期 | 2024/09/18 | ||||||
| 药物ATC编码 |
申请类型 | 附件文件下载 | 市场状态 | Withdrawn（注：已撤市） | 撤市原因：2.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided could allow to conclude on a positive benefit-risk balance if the points for clarification identified were solved. |